COMMENTARY

MHLW Panel Elaborating Rules for Clinical Research Law, “Scholarship Donations” to Be a Major Focus

August 21, 2017
By Hiroyasu Onishi The Clinical Research Law was enacted and promulgated in April, and a dedicated health ministry panel kicked off earlier this month to discuss the specifics before its enforcement sometime within a year of the promulgation. The largest…

To read the full story

Related Article

COMMENTARY

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…